Incidence of diabetes mellitus following hospitalisation for COVID ‐19 in the United Kingdom: A prospective observational study
Authors' conclusion
Diabetes incidence following hospitalisation for COVID-19 is high, but it remains uncertain whether it is disproportionately higher than pre-pandemic levels.
Study context
- Population
- Adults ≥18 years discharged from NHS hospitals across the UK after COVID-19 (PHOSP-COVID), ≥1 research visit with HbA1c within 14 months of discharge, no history of diabetes at baseline
- Exposure
- Ethnic groups; incidence vs UK clinical trial control groups
- Outcome
- New onset diabetes (any type): first HbA1c ≥6.5% (≥48 mmol/mol)
Methodological detailsmulticentre, prospective observational
- Multicentre
- Prospective observational
Main finding
As reported in the abstract
Incidence of diabetes
Each group vs whiteIncidence rate ratio (CI)P value
South Asian
3.60(1.77–7.32)
P < 0.001Black
2.36(1.07–5.21)
P = 0.03- Incidence of diabetes, overall
- 91.4 per 1000 person-years
Observational data: associations, not effects.
Further findings
Incidence vs UK clinical trial control groups, restricted to similar characteristics
- Incidence rates similar to those in UK clinical trials data
Original publication
Incidence of diabetes mellitus following hospitalisation for COVID ‐19 in the United Kingdom: A prospective observational study. Diabetes Obes Metab. Published 20 November 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →